Medium materiality6/10
ProMIS Neurosciences initiated with a Buy at Roth Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Roth Capital initiates PMN with Buy; target 19 vs current 13.55.
- Roth Capital initiates PMN with Buy; target 19 vs 13.55
Key facts
- 01
Target: $19
- 02
Posted price: $13.55
- 03
Analyst firm: Roth Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.